Kannan Lakshmi, Kotus-Bart Justyna, Amanullah Aman
Department of Endocrinology, University of Pennsylvania, Philadelphia, PA, USA.
Department of Medicine, Pinnacle Health, Harrisburg, PA, USA.
Horm Metab Res. 2017 Jun;49(6):430-433. doi: 10.1055/s-0043-105275. Epub 2017 May 4.
The thyroid functions as a regulator of cardiac function and rhythm through genomic and nongenomic actions of triiodothyronine (T3) in cardiac myocytes. Atrial fibrillation is a common complication of thyrotoxicosis. Hypothyroidism is not considered a risk factor for arrhythmias despite well-known EKG changes in this condition. This case control study was conducted to analyze the differences, if any, in the prevalence of cardiac arrhythmias between hypothyroid patients and euthyroid controls. Three hundred and four consecutive patients admitted at our medical center for a period of one year were included in the study. The study population was divided into 2 groups (age, gender and race matched): patients with hypothyroidism and euthyroid subjects as a control group. Major arrhythmia data were obtained from telemetry recordings and from known past medical history. There were 152 subjects in each arm of the study. The mean age was 61.9 years. Mean TSH in hypothyroid group was 40.4 mIU/l (95% CI 33.3-47.5) (range 10.09-304, SE 3.62) and in euthyroid group was 0.89 mIU/l (95% CI 0.82-0.96). Chi-square analysis revealed a higher prevalence of ventricular tachycardia (p=0.04) and any ventricular arrhythmia in the hypothyroid group (p=0.007). This relatively large case control study revealed a statistically higher prevalence of ventricular arrhythmias in hypothyroidism. Our study has thrown light on the prevalence of arrhythmias in hypothyroidism and the observation of increased ventricular arrhythmias necessitates future large scale prospective studies to better define the risk of such ventricular arrhythmias and the effects of thyroid supplementation on this risk.
甲状腺通过心肌细胞中三碘甲状腺原氨酸(T3)的基因组和非基因组作用,发挥心脏功能和节律调节器的作用。心房颤动是甲状腺毒症的常见并发症。尽管甲状腺功能减退症存在众所周知的心电图变化,但它不被视为心律失常的危险因素。本病例对照研究旨在分析甲状腺功能减退患者与甲状腺功能正常对照组之间心律失常患病率的差异(如有)。本研究纳入了在我们医疗中心连续一年收治的304例患者。研究人群分为2组(年龄、性别和种族匹配):甲状腺功能减退患者组和甲状腺功能正常受试者作为对照组。主要心律失常数据来自遥测记录和已知的既往病史。研究的每组有152名受试者。平均年龄为61.9岁。甲状腺功能减退组的平均促甲状腺激素(TSH)为40.4 mIU/l(95%可信区间33.3 - 47.5)(范围10.09 - 304,标准误3.62),甲状腺功能正常组为0.89 mIU/l(95%可信区间0.82 - 0.96)。卡方分析显示,甲状腺功能减退组室性心动过速(p = 0.04)和任何室性心律失常的患病率更高(p = 0.007)。这项规模相对较大的病例对照研究显示,甲状腺功能减退症患者室性心律失常的患病率在统计学上更高。我们的研究揭示了甲状腺功能减退症中心律失常的患病率,观察到室性心律失常增加,有必要开展未来的大规模前瞻性研究,以更好地界定此类室性心律失常的风险以及甲状腺补充治疗对此风险产生的影响。